TVM Capital Life Science

TVM is a leading international venture capital firm focused on investing in life science innovations. The company has a highly experienced transatlantic investment team and approximately $900 million under management. TVMs portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care. TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC) that leverages the firms strategic relationship with global pharmaceutical firm, Eli Lilly and Company. TVM also invests in differentiated commercial-stage medical technologies...

Venture capital,growth capital,international,life science,innovation,drug development,biotech,medtech,healthtech,diagnostics,drug development,and medical technologies

Tvm capital life science operates in the Venture capital and private equity principals industry.

Tvm capital life science's revenue is 11m - 100m

Tvm capital life science has 11 - 50 employees.